Nicotinic Neuronal Acetylcholine Receptor α‐3 Subunit Transcription in Normal and Myasthenic Thymus a

Thymic transcription of the alpha-3 subunit of the AChR was studied through sequencing and PCR analysis of thymic cDNA clones, Northern blotting, and ribonuclease protection assays. This analysis revealed at least three, 3' end sequence variants for the alpha-3 subunit as well as a variant that results from the alternative splicing of an antisense 122 bp Alu sequence between exons 5 and 6 of the normal transcript. The spliced Alu sequence not only shifts the exon 6 reading frame but also carries an in-frame stop codon. If translated, this variant transcript would produce a truncated peptide lacking the fourth transmembrane domain of the subunit and carrying a carboxy terminus dodecapeptide not found in any other known AChR subunit sequence. The putative variant subunit may lack biological activity and should differ antigenically from its normal counterpart. In comparing the normal, the MG hypertrophic, and the MG thymoma for transcription of the alpha-3 subunit and its 122 bp variant, it was found that there were no qualitative or quantitative changes in alpha-3 transcript expression in the MG hypertrophic thymi. Thymomas, however, showed an overall decrease in alpha-3 transcription and a comparative increase in beta-amyloid precursor transcription. The decrease in the levels of alpha-3 transcription in thymomas may be related to the proliferation of thymic epithelial cells.

[1]  H. Link,et al.  Immunological specificity and cross-reactivity of anti-acetylcholine receptor and anti-presynaptic membrane receptor antibodies in myasthenia gravis , 1991, Journal of the Neurological Sciences.

[2]  A. Roses,et al.  Expression of mRNAs in human thymus coding for the α3 subunit of a neuronal acetylcholine receptor , 1991, Experimental Neurology.

[3]  C. Obie,et al.  Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: a role for Alu elements in human mutation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Boyd,et al.  Towards an integrated view of thymopoiesis. , 1991, Immunology today.

[5]  D. Gottlieb,et al.  Developmentally regulated expression of an exon containing a stop codon in the gene for glutamic acid decarboxylase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Vincent,et al.  The human muscle nicotinic acetylcholine receptor alpha‐subunit exist as two isoforms: a novel exon. , 1990, The EMBO journal.

[7]  H. Müller-Hermelink,et al.  Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[8]  C. Gotti,et al.  The α-bungarotoxin receptor purified from a human neuroblastoma cell line: Biochemical and immunological characterization , 1989, Neuroscience.

[9]  A. Nezu,et al.  Peripheral nerve involvement in myasthenia gravis , 1989, Brain and Development.

[10]  J. Malter,et al.  Identification of an AUUUA-specific messenger RNA binding protein. , 1989, Science.

[11]  K. Müller Anti-neuroblastoma antibodies in myasthenia gravis: clinical and immunological correlations , 1989, Journal of the Neurological Sciences.

[12]  L. Swanson,et al.  Genes encoding neuronal nicotinic acetylcholine receptors. , 1989, Clinical chemistry.

[13]  K. Tamai,et al.  Coordinate regulation of RNAs encoding two isoforms of the rat muscle nicotinic acetylcholine receptor beta-subunit. , 1989, Nucleic acids research.

[14]  D. Labuda,et al.  Sequence conservation in Alu evolution. , 1989, Nucleic acids research.

[15]  L. Bell,et al.  Sex-lethal, a Drosophila sex determination switch gene, exhibits sex-specific RNA splicing and sequence similarity to RNA binding proteins , 1988, Cell.

[16]  H. Vinters,et al.  Immunohistochemical study of cerebral amyloid angiopathy. II. Enhancement of immunostaining using formic acid pretreatment of tissue sections. , 1988, The American journal of pathology.

[17]  D. Roeltgen,et al.  Memory dysfunction in myasthenia gravis , 1988, Neurology.

[18]  D. K. Berg,et al.  Expression and regulation of neuronal acetylcholine receptor mRNA in chick ciliary ganglia , 1988, Neuron.

[19]  H. Emonard,et al.  Thymic extracellular matrix in myasthenia gravis II. Immunohistochemical evidence for increased type I collagen degradation , 1988, Journal of Neuroimmunology.

[20]  C. Pénit,et al.  Sequential events in thymocyte differentiation and thymus regeneration revealed by a combination of bromodeoxyuridine DNA labeling and antimitotic drug treatment. , 1988, Journal of immunology.

[21]  P. Nef,et al.  Genes expressed in the brain define three distinct neuronal nicotinic acetylcholine receptors. , 1988, The EMBO journal.

[22]  H. Müller-Hermelink,et al.  Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. , 1988, The American journal of pathology.

[23]  F. Magni,et al.  The afferent innervation of the thymus gland in the rat , 1987, Brain Research.

[24]  K. Tanaka,et al.  Effects of substitution of putative transmembrane segments on nicotinic acetylcholine receptor function , 1987, FEBS letters.

[25]  M. Schluep,et al.  Acetylcholine receptors in human thymic myoid cells in situ: An immunohistological study , 1987, Annals of neurology.

[26]  S. Heinemann,et al.  Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system , 1987, Cell.

[27]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[28]  V. Nussenzweig,et al.  Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins , 1987, Nature.

[29]  B. Haynes,et al.  Human thymic epithelial cells function as accessory cells for autologous mature thymocyte activation. , 1987, Journal of immunology.

[30]  G. Janossy,et al.  Myasthenia Gravis: Immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown , 1986, Journal of Neuroimmunology.

[31]  T. Roszman,et al.  Neural modulation of immune function , 1985, Journal of Neuroimmunology.

[32]  G. Janossy,et al.  Microenvironments in the normal thymus and the thymus in myasthenia gravis. , 1985, The American journal of pathology.

[33]  H. Colten,et al.  Isolation and sequence analysis of a cDNA clone encoding the fifth complement component. , 1985, The Journal of biological chemistry.

[34]  K. Bulloch,et al.  Autonomic nervous system innervation of thymic‐related lymphoid tissue in wildtype and nude mice , 1984, The Journal of comparative neurology.

[35]  R. Lang,et al.  Myasthenia Gravis Identification of Skeletal and Heart Muscle antigens not related to the acetylcholine receptor , 1984, Journal of Neuroimmunology.

[36]  N. Gilhus,et al.  Myasthenia gravis , 1984, Neurology.

[37]  N. Gilhus,et al.  Myasthenia gravis antibodies to skeletal muscle cell surface antigens , 1983, Journal of Neuroimmunology.

[38]  J. Bogousslavsky,et al.  Encephalopathy, peripheral neuropathy, dysautonomia, myasthenia gravis, malignant thymoma, and antiacetylcholine receptor antibodies in the CSF. , 1983, European neurology.

[39]  S. Self,et al.  Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. , 1982, The New England journal of medicine.

[40]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[41]  S. Latt,et al.  Regional localization on the human X of DNA segments cloned from flow sorted chromosomes. , 1982, Nucleic acids research.

[42]  D. Felten,et al.  Sympathetic innervation of murine thymus and spleen: A comparative histofluorescence study , 1981, The Anatomical record.

[43]  C. Olanow,et al.  No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis , 1981, Neurology.

[44]  W. Engel,et al.  THYMIC EPITHELIAL CELL CONTAINS ACETYLCHOLINE RECEPTOR , 1977, The Lancet.

[45]  D. Drachman,et al.  Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. , 1977, Science.

[46]  Ó. Papazian,et al.  Rapid eye movement sleep alterations in myasthenia gravis , 1976, Neurology.

[47]  A. J. Strauss,et al.  Myasthenia gravis. Immunological relationship between striated muscle and thymus. , 1966, Lancet.